SEC Company Response from JOHNSON & JOHNSON (JNJ) (CIK 0000200406) (JNJ) — Jul 24, 2019
JOHNSON & JOHNSON (JNJ) (CIK 0000200406)
Date: July 24, 2019 · CIK: 0000200406 · Accession: 0000200406-19-000051
AI Filing Summary & Sentiment
File numbers found in text: 001-03215
Referenced dates: July 18, 2019
Show Raw Text
CORRESP 1 filename1.htm Document Ronald A. Kapusta Vice President Corporate Controller One Johnson & Johnson Plaza New Brunswick, NJ 08933 July 24, 2019 Via EDGAR Ms. Ibolya Ignat Ms. Angela Connell Division of Corporation Finance Office Healthcare & Insurance U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Re: Johnson & Johnson Form 10-K for the Fiscal Year Ended December 30, 2018 Filed January 22, 2019 Form 8-K dated January 22, 2019 Filed January 22, 2019 File No. 001-03215 Dear Ms. Ignat and Ms. Connell: We have received the comment letter dated July 18, 2019 (the “comment letter”) from the Securities and Exchange Commission (the “Commission”) to Mr. Joseph J. Wolk, Chief Financial Officer, in which the staff of the Commission has requested certain information with respect to the above-referenced Form 10-K and Form 8-K. As discussed with Ms. Connell, we would like to respectfully request an extension for our response to the comment letter to no later than Friday, August 30. This extension will ensure that we can devote the appropriate time and resources to consider the Staff’s comments and prepare our response. If you have any questions, please contact me at 732-524-6567. Sincerely, /s/ Ronald A. Kapusta Vice President Corporate Controller Chief Accounting Officer